WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 27-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 2'0901 Infant (under 12 months) mortality rate: 342
GDP / capita (US$): 5'5761 Child (under 5 years) mortality rate: 392

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 29'893  29'470  29'033  28'592  28'158  24'518  20'515  15'952 
Births 667  671  671  666  658  550  697  557 
Surviving infants 639  642  641  637  629  522  654  516 
Pop. less than 5 years 3'195  3'171  3'135  3'078  2'991  2'741  3'270  2'415 
Pop. less than 15 years 8'526  8'409  8'301  8'208  8'129  9'033  8'392  6'528 
Female 15-49 years 8'298  8'236  8'168  8'091  8'006  6'394  4'797  3'660 

Number of reported cases

(Click for retrospective incidence data for Uzbekistan)
Diphtheria
ChartChart
  12 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  22  476  80  3'943 
Mumps
ChartChart
  2'336  3'256  2'300  1'160  3'949 
Pertussis
ChartChart
  69  42  62  36  77  713 
Polio*
ChartChart
 
Rubella
ChartChart
  23  454 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Uzbekistan)
Vaccine year result method % card seen                                                
BCG 2005  100  MICS   96  99*  99*  99*  99*  99*  98 
DTP1 2005  99  MICS   96  99  99*  99*  99*  99  97 
DTP3 2005  93  MICS   96  99  99*  99  99  99  99 
DTP4          99  99* 
IPV1         
HepB_BD          99*  99*  99*  99*  99* 
HepB3 2005  90  MICS   96  99  99*  99  99  99 
Hib3          99  99*  99  99  99 
JapEnc         
MCV1          99*  99*  97  99*  99*  99 
MCV2          99*  99*  99*  99*  99*  99 
PCV1          99* 
PCV3         
Pol3 2005  90  MICS   96  99*  99*  99  99*  99*  99 
Rota1          97  99* 
RotaC          95  99* 
Rubella1          99*  99*  97  99*  99* 
TT2plus         
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Uzbekistan)
BCG
ChartChart
  99  99  99  99  98 
DTP1
ChartChart
  99  99  99  99  99 
DTP3
ChartChart
  99  99  99  99  99 
HepB3
ChartChart
  99  99  99  99 
HepB_BD
ChartChart
  99  99  99  99 
Hib3
ChartChart
  99  99  99  99 
MCV1
ChartChart
  99  97  99  99  99 
MCV2
ChartChart
  99  99  99  99  98 
PCV3
ChartChart
 
Pol3
ChartChart
  99  99  99  99  99 
RotaC
ChartChart
  52 

Number of districts in the country 196  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 3 days; Yes
DTwP 16 months; Yes
DTwPHibHepB 2, 3, 4 months; Yes
HepA No based on epidemiological indications
HepB_Adult Yes based on epidemiological indications
HepB_Pediatric birth; Yes
Influenza_Adult Yes elderly and adults with chronic diseases, health care workers, Haj and travelers
Influenza_Pediatric Yes children and those with chronic diseases
MMR 1, 6 years; Yes
Measles No based on epidemiological indications
MenACWY No per request
OPV 3 days; 2, 3, 4, 16 months; 7 years; Yes
Pneumo_conj 2, 3, 12 months; Yes
Rotavirus 2, 3 months; Yes
TT Yes all ages based on epidemiological indications
Td 7, 16 years; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2018  2010-2015  2010-2015  2010-2015  2010-2015  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 196  195  194  195    199   

System performance

Total Nº districts in country number 196  195  196  195  199  199  199 
Nº districts with DTP3 coverage >=80% number 196  195  196    199  199  199 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100    100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 196  195  196    199  147  142 
% of districts with MCV1 coverage >=95% From 0 to 100% 100  100  100    100  74  71 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 80  72      11   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes         

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.